SIVEXTRO

This brand name is authorized in Austria, Brazil, Estonia, Spain, Finland, France, Ireland, Japan, Lithuania, Mexico, Poland, Singapore, United Kingdom, United States

Active ingredients

The drug SIVEXTRO contains one active pharmaceutical ingredient (API):

1 Tedizolid UNII O7DRJ6R4DW - TEDIZOLID PHOSPHATE

Tedizolid is an oxazolidinone prodrug. The antibacterial activity of tedizolid is mediated by binding to the 50S subunit of the bacterial ribosome resulting in inhibition of protein synthesis. Tedizolid is primarily active against Gram-positive bacteria. Read about Tedizolid

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SIVEXTRO Powder for concentrate for solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC
SIVEXTRO Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01XX11		J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XX Other antibacterials
Discover more medicines within J01XX11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 525519060021113, 525519060021213, 538918050028602, 538918050028702
Country: EE	Ravimiamet	Identifier(s): 1680982, 1680993, 1681006
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 115991001, 115991003
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 036161, 066893
Country: FR	Base de données publique des médicaments	Identifier(s): 69945545
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 297229, 297232
Country: JP	医薬品医療機器総合機構	Identifier(s): 6249003F1029, 6249402D1026
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1076036, 1076037, 1076038
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 144M2016, 149M2016
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100342559, 100342571
Country: SG	Health Sciences Authority	Identifier(s): 14850P, 14851P
Country: US	FDA, National Drug Code	Identifier(s): 67919-040, 67919-041